News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Daiichi Sankyo To Buy Astellas Pharma Inc. OTC Drug Unit, Zepharma Inc. For $200 Million



3/31/2006 11:25:19 AM

Takashi Shoda (R), president of Daiichi Sankyo Co., and Masaji Oe, president of Zepharma Inc., stellas Pharma Inc.'s nonprescription drug unit, shake hands at a news conference at Daiichi Sankyo's head office in Tokyo on March 31. They announced Daiichi Sankyo will buy Zepharma for 23.5 billion yen. (Kyodo)


Read at press release
Read at Reuters
Read at press release
Read at Bloomberg


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES